CORIXA
Corixa is a developer of immunotherapeutics with a commitment to treating and preventing autoimmune diseases, cancer and infectious diseases by understanding and directing the immune system. Having founded in 1994, the company conducted various preclinical development programs, including the BEXXAR® therapy and the MELACINE® vaccine. Corixa is focused on immunotherapeutic products and has a broad technology platform enabling both fully integrated vaccine design and the use of it... s separate, proprietary product components on a standalone basis. The company partners with numerous developers and marketers of pharmaceuticals, targeting products that are powered by Corixa™ technology with the goal of making its potential products available to patients around the world. Corixa was acquired by GlaxoSmithKline on 12 July 2005, and GSK had formerly made use of the Corixa's MPL adjuvant in some of their vaccines. The company ceased operations in March 2006.
CORIXA
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
1994-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.coulterpharm.com
Total Employee:
1+
Status:
Active
Contact:
4063752206
Total Funding:
15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Nginx YouTube Facebook Sharer CloudFront Google Adsense AWS Global Accelerator AdBlock Acceptable Ads
Current Advisors List
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2000-10-16 | Coulter Corporation | Coulter Corporation acquired by Corixa | N/A |
| 1998-06-23 | GenQuest | GenQuest acquired by Corixa | 11.8 M USD |
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Venture Round - Corixa
Kleiner Perkins
Kleiner Perkins investment in Series A - Corixa
Enterprise Partners
Enterprise Partners investment in Series A - Corixa
OVP Venture Partners
OVP Venture Partners investment in Series A - Corixa
InterWest Partners
InterWest Partners investment in Series A - Corixa
Forward Ventures
Forward Ventures investment in Series A - Corixa
Official Site Inspections
http://www.coulterpharm.com
- Host name: lb-182-253.above.com
- IP address: 103.224.182.253
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
